Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres. Επικοινωνία Submitted by Δημήτρης Σπάχος on Παρ, 12/04/2020 - 20:58
